… In summary, stem cell therapy is an exciting area of investigation. With further validation,
the Flk + /VE-cadherin + isolated ESC-ECs described here could provide a continual source of …

… aimed at inhibiting cell death may provide novel therapies for these common and lethal … to
cell death during myocardial infarction and heart failure in the section on heart disease below. …

… Heart valve replacement by mechanical or biological valve … common treatment for advanced
valvular heart disease. The major … cells, there has also been substantial work on therapies to …

… The first major clinical trial of stem cell therapy in peripheral vascular disease was the
Therapeutic Angiogenesis using Cell Transplantation study, demonstrating safety and providing …

… Taken as a whole, our results with gene therapy approaches for heart diseases showed that
… Regarding cell therapy for cardiovascular diseases, our results in preclinical and clinical …

… of patients with ischemic heart disease. Clinical efficacy data are … heart function in cell-treated
patients. This review is an attempt to describe the scientific basis for cardiac cell therapy …

… animals receiving myoblast cell therapy (MI+cell). In vivo and ex vivo cardiac physiology and
myoblast cell survival were studied at 3 and 6 weeks after cell therapy. Cell grafts were also …

… Ischemic heart disease remains the leading cause of chronic heart failure (CHF). The
prevalence of CHF has increased dramatically over the last three decades, with more than 10% of …

… cell therapy may be feasible in patients. The overall clinical experience also suggests that
stem cell therapy can be safely performed, if the right cell … severe ischemic heart disease, it …

… heart failure who desperately need heart transplantation. A major challenge to stem cell
therapy is that transplanted stem cells … microenvironment in the infarcted heart. In addition to …